Year | Author | N | Onset (day) median, range | Clinical presentation (n) | Surgical treatment (n) | Endovascular therapy (n) | None (n) | Outcome alive/total |
---|---|---|---|---|---|---|---|---|
2013 | Saad | 20 | 48, 1–1098 | Hypotension (12) GI-bleeding (7) Sepsis (2) Dropped hematocrit without symptoms (1) | Surgery (2) | 1/2 | ||
Embolization (4) (selective embolization (1)) | 1/4 | |||||||
Stent-graft (8)(+ ReOLT (1)) | 6/8 | |||||||
ReOLT (5) | 5/5 | |||||||
None (1) | 0/1 | |||||||
2013 | Panaro | 9 | 39.6, 22–92 | Bleeding (4), fever (3) asymptomatic (3) | Revascularization with saphenous bypass (9)(+ ReOLT (1)) | 8/9 | ||
2013 | Boleslawski | 17 | 29, 2–92 | Hemo peritoneum (10) GI-bleeding (5) Hemobilia (1) Hematoma (1) | Anastomosis revision (5)(+ ReOLT (1)) | 1/5 | ||
HA ligation (10)(+ ReOLT (3)) | 6/10 | |||||||
Embolization (1) | 0/1 | |||||||
None (1) | 0/1 | |||||||
2014 | Volpin | 16 | 13, 4–100 | Shock (10) GI-bleeding (4) Bleed through drains (5) Abdominal pain (8) | Excision + revascularization (7) | 4/7 | ||
Ligation (5)(+ ReOLT (1)) | 2/5 | |||||||
Embolization (1) | 1/1 | |||||||
Covered stent (1) | 1/1 | |||||||
None (2) | 0/2 | |||||||
2017 | Thorat | 2a | 7, 2.5 Mo | Bleeding (2) | Stent graft (2) | 2/2 | ||
2022 | Kadohisa | 3 | 41, 68, 19 Mo | GI-bleeding (3) | Embolization (3) (+ revascularization (1) + ReOLT(1)) | 2/3 | ||
2023 | This case | 1 | 7 Mo | Abdominal pain, fever | Embolization (1) | 1/1 |